L1 Global Manager’s Bluejay Diagnostics BJDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$103 Hold
30
– – ﹤0.01% 127
2026
Q2
$144 Hold
30
– – ﹤0.01% 121
2026
Q1
$220 Hold
30
– – ﹤0.01% 116
2025
Q4
$226 Buy
+30
New +$788 ﹤0.01% 94

Other funds holding BJDX

L1 Global Manager's BJDX Position: Q3 2026 in Review

L1 Global Manager held its Bluejay Diagnostics (BJDX) position steady in Q3 2026 at 30 shares worth $103. The position accounts for ﹤0.01% of the portfolio, ranked #127.

L1 Global Manager first reported a position in BJDX in Q4 2025 and has held it in 4 quarters since. The position peaked at $226 in Q4 2025. 13 funds tracked by Wall St. Rank hold BJDX as of Q3 2026.

  • L1 Global Manager held 30 shares of Bluejay Diagnostics worth $103 as of Q3 2026.
  • L1 Global Manager left its Bluejay Diagnostics share count unchanged in Q3 2026.
  • Bluejay Diagnostics made up ﹤0.01% of L1 Global Manager's portfolio in Q3 2026, its #127 holding.
  • L1 Global Manager first reported a position in Bluejay Diagnostics in Q4 2025 and has held it in 4 quarters since.
  • L1 Global Manager's Bluejay Diagnostics position peaked at $226 in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2026.

Based on L1 Global Manager's 13F filing for Q3 2026, filed 16 Nov 2026.